Literature DB >> 22205749

Regulation of cyclin T1 and HIV-1 Replication by microRNAs in resting CD4+ T lymphocytes.

Karen Chiang1, Tzu-Ling Sung, Andrew P Rice.   

Abstract

The replication of integrated human immunodeficiency virus type 1 (HIV-1) is dependent on the cellular cofactor cyclin T1, which binds the viral Tat protein and activates the RNA polymerase II transcription of the integrated provirus. The activation of resting CD4(+) T cells upregulates cyclin T1 protein levels independently of an increase in cyclin T1 mRNA levels, suggesting a translational repression of cyclin T1 in resting CD4(+) T cells. Hypothesizing that microRNAs (miRNAs) repress cyclin T1 translation in resting CD4(+) T cells and that this inhibition is lifted upon cell activation, we used microarray expression analysis to identify miRNAs miR-27b, miR-29b, miR-150, and miR-223 as being significantly downregulated upon CD4(+) T cell activation. The overexpression of these miRNAs decreased endogenous cyclin T1 protein levels, while treatment with the corresponding antagomiRs increased cyclin T1 protein levels. An miR-27b binding site within the cyclin T1 3' untranslated region (3'UTR) was identified and confirmed to be functional after the mutation of key resides abrogated the ability of miR-27b to decrease the expression of a luciferase reporter upstream of the cyclin T1 3'UTR. Ago2 immunoprecipitation revealed an association with cyclin T1 mRNA that was decreased following treatment with miR-27b and miR-29b antagomiRs. Cells overexpressing miR-27b showed decreased viral gene expression levels of the HIV-1 reporter virus and a decreased replication of strain NL4.3; a partial rescue of viral transcription could be seen following the transfection of cyclin T1. These results implicate miR-27b as a novel regulator of cyclin T1 protein levels and HIV-1 replication, while miR-29b, miR-223, and miR-150 may regulate cyclin T1 indirectly.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22205749      PMCID: PMC3302325          DOI: 10.1128/JVI.05065-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

1.  miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely.

Authors:  Beiyan Zhou; Stephanie Wang; Christine Mayr; David P Bartel; Harvey F Lodish
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-16       Impact factor: 11.205

2.  Induction of TAK (cyclin T1/P-TEFb) in purified resting CD4(+) T lymphocytes by combination of cytokines.

Authors:  R Ghose; L Y Liou; C H Herrmann; A P Rice
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

3.  Cyclin T1 expression is regulated by multiple signaling pathways and mechanisms during activation of human peripheral blood lymphocytes.

Authors:  Renée M Marshall; Dominic Salerno; Judit Garriga; Xavier Graña
Journal:  J Immunol       Date:  2005-11-15       Impact factor: 5.422

4.  Specific inhibition of HIV-1 replication by short hairpin RNAs targeting human cyclin T1 without inducing apoptosis.

Authors:  Zhaoyang Li; Yong Xiong; Yu Peng; Ji'an Pan; Yu Chen; Xiaoyun Wu; Snawar Hussain; Po Tien; Deyin Guo
Journal:  FEBS Lett       Date:  2005-06-06       Impact factor: 4.124

5.  Mammalian microRNAs predominantly act to decrease target mRNA levels.

Authors:  Huili Guo; Nicholas T Ingolia; Jonathan S Weissman; David P Bartel
Journal:  Nature       Date:  2010-08-12       Impact factor: 49.962

6.  MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb.

Authors:  Changchun Xiao; Dinis Pedro Calado; Gunther Galler; To-Ha Thai; Heide Christine Patterson; Jing Wang; Nikolaus Rajewsky; Timothy P Bender; Klaus Rajewsky
Journal:  Cell       Date:  2007-10-05       Impact factor: 41.582

7.  Inhibition of human immunodeficiency virus type 1 replication by RNA interference directed against human transcription elongation factor P-TEFb (CDK9/CyclinT1).

Authors:  Ya-Lin Chiu; Hong Cao; Jean-Marc Jacque; Mario Stevenson; Tariq M Rana
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

8.  Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes.

Authors:  Jialing Huang; Fengxiang Wang; Elias Argyris; Keyang Chen; Zhihui Liang; Heng Tian; Wenlin Huang; Kathleen Squires; Gwen Verlinghieri; Hui Zhang
Journal:  Nat Med       Date:  2007-09-30       Impact factor: 53.440

9.  Post-transcriptional regulation of miR-27 in murine cytomegalovirus infection.

Authors:  Amy H Buck; Jonathan Perot; Michael A Chisholm; Diwakar S Kumar; Lee Tuddenham; Valérie Cognat; Lisa Marcinowski; Lars Dölken; Sébastien Pfeffer
Journal:  RNA       Date:  2010-01-04       Impact factor: 4.942

10.  Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference.

Authors:  Glen A Coburn; Bryan R Cullen
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

View more
  93 in total

Review 1.  Molecular mechanisms of HIV latency.

Authors:  Daniele C Cary; Koh Fujinaga; B Matija Peterlin
Journal:  J Clin Invest       Date:  2016-01-05       Impact factor: 14.808

2.  MicroRNA biomarkers associated with type 1 myocardial infarction in HIV-positive individuals.

Authors:  Neal Yuan; Rebecca Scherzer; Kahraman Tanriverdi; Jeffrey Martin; Smruti Rahalkar; Priscilla Hsue
Journal:  AIDS       Date:  2019-12-01       Impact factor: 4.177

3.  MicroRNA 181 suppresses porcine reproductive and respiratory syndrome virus (PRRSV) infection by targeting PRRSV receptor CD163.

Authors:  Li Gao; Xue-kun Guo; Lianghai Wang; Qiong Zhang; Ning Li; Xin-xin Chen; Yongqiang Wang; Wen-hai Feng
Journal:  J Virol       Date:  2013-06-05       Impact factor: 5.103

Review 4.  MicroRNA regulation of T-lymphocyte immunity: modulation of molecular networks responsible for T-cell activation, differentiation, and development.

Authors:  Katie Podshivalova; Daniel R Salomon
Journal:  Crit Rev Immunol       Date:  2013       Impact factor: 2.214

Review 5.  HIV-1 transcription and latency: an update.

Authors:  Carine Van Lint; Sophie Bouchat; Alessandro Marcello
Journal:  Retrovirology       Date:  2013-06-26       Impact factor: 4.602

Review 6.  RNA viruses and microRNAs: challenging discoveries for the 21st century.

Authors:  Gokul Swaminathan; Julio Martin-Garcia; Sonia Navas-Martin
Journal:  Physiol Genomics       Date:  2013-09-17       Impact factor: 3.107

7.  Reactivation of latent HIV: do all roads go through P-TEFb?

Authors:  Sona Budhiraja; Andrew P Rice
Journal:  Future Virol       Date:  2013-07-01       Impact factor: 1.831

8.  Short communication: SAHA (vorinostat) induces CDK9 Thr-186 (T-loop) phosphorylation in resting CD4+ T cells: implications for reactivation of latent HIV.

Authors:  Rajesh Ramakrishnan; Hongbing Liu; Andrew P Rice
Journal:  AIDS Res Hum Retroviruses       Date:  2015-01       Impact factor: 2.205

9.  Histone deacetylase inhibitors (HDACis) that release the positive transcription elongation factor b (P-TEFb) from its inhibitory complex also activate HIV transcription.

Authors:  Koen Bartholomeeusen; Koh Fujinaga; Yanhui Xiang; B Matija Peterlin
Journal:  J Biol Chem       Date:  2013-03-28       Impact factor: 5.157

10.  Cyclin-dependent kinase 7 (CDK7)-mediated phosphorylation of the CDK9 activation loop promotes P-TEFb assembly with Tat and proviral HIV reactivation.

Authors:  Uri Mbonye; Benlian Wang; Giridharan Gokulrangan; Wuxian Shi; Sichun Yang; Jonathan Karn
Journal:  J Biol Chem       Date:  2018-05-09       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.